NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

虛擬臨床實驗的全球市場:市場規模·佔有率·趨勢分析,各部門預測 (各臨床實驗設計·各適應症·各地區)

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular), By Region, And Segment Forecasts 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 977798
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
虛擬臨床實驗的全球市場:市場規模·佔有率·趨勢分析,各部門預測 (各臨床實驗設計·各適應症·各地區) Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular), By Region, And Segment Forecasts 2020 - 2027
出版日期: 2020年11月13日內容資訊: 英文 120 Pages
簡介

全球虛擬臨床實驗的市場規模在2020年∼2027年間,預測將以5.1%的年複合成長率擴大,2027年之前達到105億美元。基於現場收集的數據的積累,對高度多樣化的臨床試驗患者數據的需求是市場的主要推動力。

本報告提供全球虛擬臨床實驗 (VCT:虛擬臨床試驗) 市場相關分析,彙整市場基本結構和主要的促進·阻礙因素,各臨床實驗設計·各適應症·各地區的市場趨勢預測 (今後8年份),主要企業的簡介與策略展開情形等資訊,為您概述為以下內容。

目錄

第1章 調查方法·範圍

第2章 摘要整理

第3章 虛擬臨床實驗市場:變動要素·趨勢·範圍

  • 市場關聯結構
  • 產品普及率·成長率預測:製圖
  • 新型冠狀病毒感染疾病 (COVID-19) 感染擴大對臨床實驗活動的影響
  • 市場動態
  • 虛擬臨床實驗:市場分析工具

第4章 虛擬臨床實驗市場:各領域分析,各臨床實驗設計

  • 各領域的儀表板
  • 市場佔有率分析:各臨床實驗設計 (最新值·預測值)
  • 市場分析:各臨床實驗設計 (最新值·預測值)
  • 市場規模·趨勢分析 (最新值·預測值)
    • 干預
    • 觀察
    • 接入

第5章 虛擬臨床實驗市場:各領域分析,各適應症

  • 各領域的儀表板
  • 市場佔有率分析:各適應症 (最新值·預測值)
  • 市場分析:各適應症 (最新值·預測值)
  • 市場規模·趨勢分析 (最新值·預測值)
    • 腫瘤
    • 心血管疾病
    • 其他

第6章 虛擬臨床實驗市場:各地區的市場分析

  • 各地區的儀表板
  • 市場佔有率分析:各地區 (最新值·預測值)
  • 市場規模·趨勢分析 (最新值·預測值)
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 印度
    • 日本
    • 中國
    • 澳洲
    • 韓國
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 中東·非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第7章 虛擬臨床實驗市場:競爭分析

  • 分析對象的主要企業
    • ICON, plc
    • PAREXEL International Corporation
    • IQVIA
    • Covance
    • PRA Health Sciences
    • LEO Innovation Lab
    • Medidata
    • Oracle
    • CRF Health
    • Clinical Ink
    • Medable
目錄
Product Code: GVR-4-68039-239-7

Virtual Clinical Trials Market Growth & Trends:

The global virtual clinical trials market size is expected to reach USD 10.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.1% from 2020 to 2027. The need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.

There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical experiments. Virtual laboratory trials eliminate challenges posed by traditional laboratory experiments, for example, delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of the people favored a mobile experiment over traditional methods, and 80.0% of patients are more likely to participate in an experiment that uses mobile technology.

The current pandemic of COVID-19 is making the clinical trial industry to change the way of conducting ongoing or upcoming lab experiments. The pandemic, for the first time in history, has resulted in the global disruption of traditional onsite lab experiments. Hence, the regulatory bodies such as the U.S. FDA, the European Medicines Agency (EMA), the National Institutes of Health (NIH), and China's National Medical Products Administration have issued guidelines related to the conduct of lab experiments during the outbreak of coronavirus, and are in complete support of incorporating virtual services.

Virtual clinical trials make use of monitoring devices, software apps, and online social engagement platforms to conduct every step of the research process including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring have been gaining momentum as a healthcare offering, and the COVID-19 is adding more horsepower to this initiative.

Virtual Clinical Trials Market Report Highlights:

  • The oncology segment alone held 25.0% of market share in 2019. The increasing adoption of virtual experiments especially in oncology laboratory research for diverse population is responsible for the growth.
  • The interventional design segment accounted for the largest revenue share of 46.5% in 2019.
  • North America held 49.7% of the market share in 2019. Favorable government initiatives and presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth.
  • In Asia Pacific, the market is expected to witness the fastest CAGR of 6.2% over the forecast period owing to the increasing patient pool and cost efficient services.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Study design
    • 1.1.2. Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Virtual Clinical Trials Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. COVID-19 pandemic impact on clinical trial activity
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. The growing role of technology in healthcare
      • 3.4.1.2. Benefits of virtual trials
      • 3.4.1.3. Government support
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Data Security
    • 3.4.3. Industry Challenge
  • 3.5. Virtual Clinical Trials: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape

Chapter 4. Virtual Clinical Trials Market: Segment Analysis, By Study Design, 2016 - 2027 (USD Million)

  • 4.1. Segment Dashboard
  • 4.2. Study Design Market Share Analysis, 2019 & 2027
  • 4.3. Global Virtual Clinical Trials Market, By Study Design, 2016 to 2027
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
    • 4.4.1. Interventional
    • 4.4.2. Observational
    • 4.4.3. Expanded Access

Chapter 5. Virtual Clinical Trials Market: Segment Analysis, By Indication, 2016 - 2027 (USD Million)

  • 5.1. Segment Dashboard
  • 5.2. Indication Market Share Analysis, 2019 & 2027
  • 5.3. Global Virtual Clinical Trials Market, By Indication, 2016 to 2027
  • 5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
    • 5.4.1. Oncology
    • 5.4.2. Cardiovascular
    • 5.4.3. Others

Chapter 6. Virtual Clinical Trials Market: Regional Market Analysis, 2016 - 2027 (USD Million)

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2019 & 2027
  • 6.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
  • 6.4. North America
    • 6.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.4.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
    • 6.4.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.4.4. U.S.
      • 6.4.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.4.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.4.5. Canada
      • 6.4.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.4.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.5.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
    • 6.5.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.5.4. Germany
      • 6.5.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.5.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.5.5. U.K.
      • 6.5.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.5.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.5.6. France
      • 6.5.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.5.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.5.7. Italy
      • 6.5.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.5.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.5.8. Spain
      • 6.5.8.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.5.8.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.6.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
    • 6.6.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.6.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.6.5. Japan
      • 6.6.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.6.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.6.6. China
      • 6.6.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.6.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.6.7. Australia
      • 6.6.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.6.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.6.8. South Korea
      • 6.6.8.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.6.8.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.7.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
    • 6.7.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.7.4. Brazil
      • 6.7.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.7.5. Mexico
      • 6.7.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.7.6. Argentina
      • 6.7.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.7.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.7.7. Colombia
      • 6.7.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.7.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.8.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
    • 6.8.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.8.4. South Africa
      • 6.8.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.8.5. Saudi Arabia
      • 6.8.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
    • 6.8.6. UAE
      • 6.8.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)

Chapter 7. Virtual Clinical Trials Market: Competitive Analysis

  • 7.1. Key companies profiled
    • 7.1.1. ICON, plc
      • 7.1.1.1. Company Overview
      • 7.1.1.2. Financial Performance
      • 7.1.1.3. Product Benchmarking
      • 7.1.1.4. Strategic Initiatives
    • 7.1.2. PAREXEL International Corporation
      • 7.1.2.1. Company Overview
      • 7.1.2.2. Financial Performance
      • 7.1.2.3. Product Benchmarking
      • 7.1.2.4. Strategic Initiatives
    • 7.1.3. IQVIA
      • 7.1.3.1. Company Overview
      • 7.1.3.2. Financial Performance
      • 7.1.3.3. Product Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. Covance
      • 7.1.4.1. Company Overview
      • 7.1.4.2. Financial Performance
      • 7.1.4.3. Product Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. PRA Health Sciences
      • 7.1.5.1. Company Overview
      • 7.1.5.2. Financial Performance
      • 7.1.5.3. Product Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. LEO Innovation Lab
      • 7.1.6.1. Company Overview
      • 7.1.6.2. Financial Performance
      • 7.1.6.3. Product Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Medidata
      • 7.1.7.1. Company Overview
      • 7.1.7.2. Financial Performance
      • 7.1.7.3. Product Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. Oracle
      • 7.1.8.1. Company Overview
      • 7.1.8.2. Financial Performance
      • 7.1.8.3. Product Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. CRF Health
      • 7.1.9.1. Company Overview
      • 7.1.9.2. Financial Performance
      • 7.1.9.3. Product Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. Clinical Ink
      • 7.1.10.1. Company Overview
      • 7.1.10.2. Financial Performance
      • 7.1.10.3. Product Benchmarking
      • 7.1.10.4. Strategic Initiatives
    • 7.1.11. Medable
      • 7.1.11.1. Company Overview
      • 7.1.11.2. Financial Performance
      • 7.1.11.3. Product Benchmarking
      • 7.1.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Virtual Clinical Trials Market, By Region, 2016 - 2027 (USD Million)
  • Table 4 Global Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 5 Global Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 6 North America Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 7 North America Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 8 North America Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 9 U.S. Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 10 U.S. Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 11 Canada Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 12 Canada Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 13 Europe Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 14 Europe Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 15 Europe Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 16 U.K. Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 17 U.K. Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 18 Germany Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 19 Germany Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 20 France Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 21 France Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 22 Italy Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 23 Italy Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 24 Spain Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 25 Spain Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 28 Asia Pacific Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 29 India Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 30 India Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 31 Japan Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 32 Japan Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 33 China Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 34 China Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 35 Australia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 36 Australia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 37 South Korea Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 38 South Korea Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 39 Latin America Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 40 Latin America Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 41 Latin America Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 42 Brazil Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 43 Brazil Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 44 Mexico Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 45 Mexico Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 46 Argentina Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 47 Argentina Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 48 Colombia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 49 Colombia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 50 MEA Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
  • Table 51 MEA Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 52 MEA Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 53 South Africa Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 54 South Africa Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 55 Saudi Arabia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 56 Saudi Arabia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
  • Table 57 UAE Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
  • Table 58 UAE Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Virtual clinical trials market: Market snapshot
  • Fig. 9 Virtual clinical trials market: Market segmentation
  • Fig. 10 Virtual clinical trials market: Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Virtual clinical trials market: Driver impact
  • Fig. 14 Virtual clinical trials market: Restraint impact
  • Fig. 15 Virtual clinical trials market: Porter's five forces analysis
  • Fig. 16 Virtual clinical trials market: PESTEL analysis
  • Fig. 17 Virtual clinical trials market: Study design segment dashboard
  • Fig. 18 Virtual clinical trials market: Study design movement analysis
  • Fig. 19 Interventional market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 20 Observational market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 21 Expanded Access market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 22 Virtual clinical trials market: Indication segment dashboard
  • Fig. 23 Virtual clinical trials market: Indication movement analysis
  • Fig. 24 Oncology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 25 Cardiovascular market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 27 Global virtual clinical trials market: Regional movement analysis
  • Fig. 28 Global virtual clinical trials market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 30 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 31 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 32 Europe market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 33 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 34 Germany market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 35 France market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 36 Italy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 37 Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 39 India market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 40 Japan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 41 China market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 42 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 43 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 44 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 46 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 48 Colombia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Middle East and Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 50 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 52 UAE market estimates and forecast, 2016 - 2027 (USD Million)